Hrt Financial LP Verastem, Inc. Transaction History

Hrt Financial LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.39 - $0.71 $10,532 - $19,174	27,007 New	27,007 $11,000
Q3 2022 Nov 14, 2022	BUY	$0.92 - $11.16 $26,883 - $326,106	29,221 New	29,221 $24,000
Q2 2022 Aug 12, 2022	SELL	$1.02 - $1.83 $18,288 - $32,811	-17,930 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.06 - $2.1 $222,372 - $440,548	-209,785 Reduced 92.13%	17,930 $25,000
Q4 2021 Feb 14, 2022	BUY	$2.05 - $3.2 $221,889 - $346,364	108,239 Added 90.59%	227,715 $466,000
Q3 2021 Nov 15, 2021	BUY	$2.54 - $4.07 $303,469 - $486,267	119,476 New	119,476 $367,000
Q3 2020 Nov 13, 2020	SELL	$1.11 - $1.68 $132,063 - $199,879	-118,976 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.69 - $4.2 $201,069 - $499,699	118,976 New	118,976 $204,000
Q4 2019 Feb 14, 2020	SELL	$0.86 - $1.44 $13,130 - $21,985	-15,268 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$1.21 - $1.59 $18,474 - $24,276	15,268 New	15,268 $18,000
Q2 2019 Aug 14, 2019	SELL	$1.25 - $3.14 $69,161 - $173,733	-55,329 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$2.79 - $4.09 $154,367 - $226,295	55,329 New	55,329 $163,000
Q4 2018 Feb 15, 2019	SELL	$3.23 - $7.01 $48,844 - $106,005	-15,122 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$6.86 - $9.97 $103,736 - $150,766	15,122 New	15,122 $109,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $796M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.